Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein-Reference-Cited by-同舟云学术

Preclinical characterization of AB-506, an inhibitor of HBV replication targeting the viral core protein

Published:2022-01 Issue: Volume:197 Page:105211
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Mani Nagraj^ORCID,Cole Andrew G.,Phelps Janet R.,Ardzinski Andrzej,Burns Robbin,Chiu Tim,Cuconati Andrea,Dorsey Bruce D.,Evangelista Ellen,Fan Kristi,Guo Fang,Harasym Troy O.,Kadhim Salam,Kowalski Roseann,Kultgen Steven G.,Lee Amy C.H.^ORCID,Li Alice H.,Majeski Sara A.^ORCID,Miller Angela,Pasetka Chris,Reid Stephen P.,Rijnbrand Rene,Micolochick Steuer Holly M.^ORCID,Stever Kim,Tang Sunny^ORCID,Teng Xiaowei,Wang Xiaohe,Sofia Michael J.^ORCID

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference78 articles.

1. Capsid assembly modulators have a dual mechanism of action in primary human hepatocytes infected with hepatitis B virus;Berke;Antimicrob. Agents Chemother.,2017

2. Antiviral profiling of the capsid assembly modulator BAY41-4109 on full-length HBV genotype A-H clinical isolates and core site-directed mutants in vitro;Berke;Antivir. Res.,2017

3. Research priorities for the discovery of a cure for chronic hepatitis B: report of a workshop;Block;Antivir. Res.,2017

4. A southern blot assay for detection of hepatitis B virus covalently closed circular DNA from cell cultures;Cai;Methods Mol. Biol.,2013

5. Establishment of an inducible HBV stable cell line that expresses cccDNA-dependent epitope-tagged HBeAg for screening of cccDNA modulators;Cai;Antivir. Res.,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel mechanistic insights – A brand new Era for anti-HBV drugs;European Journal of Medicinal Chemistry;2024-12

2. Rational Design, Synthesis, and Structure–Activity Relationship of a Novel Isoquinolinone-Based Series of HBV Capsid Assembly Modulators Leading to the Identification of Clinical Candidate AB-836;Journal of Medicinal Chemistry;2024-09-04

3. Conformationally Constrained Isoquinolinones as Orally Efficacious Hepatitis B Capsid Assembly Modulators;ACS Medicinal Chemistry Letters;2024-09-03

4. Preclinical and Clinical Antiviral Characterization of Ab-836, a Potent Capsid Assembly Modulator Against Hepatitis B Virus;2024

5. Identification of novel tetrahydroquinoxaline derived phenyl ureas as modulators of the hepatitis B virus nucleocapsid assembly;European Journal of Medicinal Chemistry;2023-11